Literature DB >> 16184198

Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.

René Maehr1, Justine D Mintern, Ann E Herman, Ana-Maria Lennon-Duménil, Diane Mathis, Christophe Benoist, Hidde L Ploegh.   

Abstract

Lysosomal proteases generate peptides presented by class II MHC molecules to CD4+ T cells. To determine whether specific lysosomal proteases might influence the outcome of a CD4+ T cell-dependent autoimmune response, we generated mice that lack cathepsin L (Cat L) on the autoimmune diabetes-prone NOD inbred background. The absence of Cat L affords strong protection from disease at the stage of pancreatic infiltration. The numbers of I-A(g7)-restricted CD4+ T cells are diminished in Cat L-deficient mice, although a potentially diabetogenic T cell repertoire persists. Within the CD4+ T cell compartments of Cat L-deficient mice, there is an increased proportion of regulatory T cells compared with that in Cat L-sufficient littermates. We suggest that it is this displaced balance of regulatory versus aggressive CD4+ T cells that protects Cat L-deficient mice from autoimmune disease. Our results identify Cat L as an enzyme whose activity is essential for the development of type I diabetes in the NOD mouse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16184198      PMCID: PMC1224301          DOI: 10.1172/JCI25485

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 2.  In vivo activation of antigen-specific CD4 T cells.

Authors:  M K Jenkins; A Khoruts; E Ingulli; D L Mueller; S J McSorley; R L Reinhardt; A Itano; K A Pape
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10.

Authors:  O Annacker; R Pimenta-Araujo; O Burlen-Defranoux; T C Barbosa; A Cumano; A Bandeira
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

4.  Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling.

Authors:  W Roth; J Deussing; V A Botchkarev; M Pauly-Evers; P Saftig; A Hafner; P Schmidt; W Schmahl; J Scherer; I Anton-Lamprecht; K Von Figura; R Paus; C Peters
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

5.  Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes.

Authors:  K Honey; M Duff; C Beers; W H Brissette; E A Elliott; C Peters; M Maric; P Cresswell; A Rudensky
Journal:  J Biol Chem       Date:  2001-04-16       Impact factor: 5.157

Review 6.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

7.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

8.  A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor.

Authors:  Brigitte Goulet; Amos Baruch; Nam-Sung Moon; Madeleine Poirier; Laurent L Sansregret; Ann Erickson; Matthew Bogyo; Alain Nepveu
Journal:  Mol Cell       Date:  2004-04-23       Impact factor: 17.970

9.  Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells.

Authors:  C Driessen; R A Bryant; A M Lennon-Duménil; J A Villadangos; P W Bryant; G P Shi; H A Chapman; H L Ploegh
Journal:  J Cell Biol       Date:  1999-11-15       Impact factor: 10.539

Review 10.  Importance of lysosomal cysteine proteases in lung disease.

Authors:  P J Wolters; H A Chapman
Journal:  Respir Res       Date:  2000-11-20
View more
  37 in total

Review 1.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

Review 2.  Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.

Authors:  Melisa Bunderson-Schelvan; Andrij Holian; Raymond F Hamilton
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017       Impact factor: 6.393

3.  Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes.

Authors:  Jan Czyzyk; Octavian Henegariu; Paula Preston-Hurlburt; Raman Baldzizhar; Christine Fedorchuk; Enric Esplugues; Kim Bottomly; Frans K Gorus; Kevan Herold; Richard A Flavell
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

4.  Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.

Authors:  Eric M Jacobson; Heyi Yang; Francesca Menconi; Rong Wang; Roman Osman; Luce Skrabanek; Cheuk Wun Li; Mohammed Fadlalla; Alisha Gandhi; Vijaya Chaturvedi; Eric P Smith; Sandy Schwemberger; Andrew Osterburg; George F Babcock; Yaron Tomer
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

5.  CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients.

Authors:  Tina Fløyel; Caroline Brorsson; Lotte B Nielsen; Michela Miani; Claus Heiner Bang-Berthelsen; Martin Friedrichsen; Anne Julie Overgaard; Lukas A Berchtold; Anna Wiberg; Pernille Poulsen; Lars Hansen; Silke Rosinger; Bernhard O Boehm; Ramesh Ram; Quang Nguyen; Munish Mehta; Grant Morahan; Patrick Concannon; Regine Bergholdt; Jens H Nielsen; Thomas Reinheckel; Matthias von Herrath; Allan Vaag; Decio Laks Eizirik; Henrik B Mortensen; Joachim Størling; Flemming Pociot
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

6.  Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes.

Authors:  Rodolfo José Chaparro; Yves Konigshofer; Georg F Beilhack; Judith A Shizuru; Hugh O McDevitt; Yueh-Hsiu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

7.  Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C.

Authors:  Quang T Le; Hae-Ki Min; Han-Zhang Xia; Yoshihiro Fukuoka; Nobuhiko Katunuma; Lawrence B Schwartz
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

8.  Processing of human protryptase in mast cells involves cathepsins L, B, and C.

Authors:  Quang T Le; Gregorio Gomez; Wei Zhao; Jiang Hu; Han-Zhang Xia; Yoshihiro Fukuoka; Nobuhiko Katunuma; Lawrence B Schwartz
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

Review 9.  Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.

Authors:  Yanwen Qin; Guo-Ping Shi
Journal:  Pharmacol Ther       Date:  2011-05-12       Impact factor: 12.310

10.  Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes.

Authors:  Fang Zou; Xiaoyang Lai; Jing Li; Shuihong Lei; Lei Hu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.